MedPath

How Clinical and Personal Information Shape Physicians' Risk Judgments

Not Applicable
Not yet recruiting
Conditions
Major Adverse Cardiac Event (MACE)
Registration Number
NCT07162376
Lead Sponsor
University of Maryland, College Park
Brief Summary

Physicians often form quick judgments about the risk for serious disease when interacting with patients. Underestimating risk can lead to underuse of diagnostic testing and untreated illness, which can worsen patient outcomes. On the other hand, overestimating risk can lead to overuse of diagnostic testing, which is costly for health systems.

To form judgments of risk, physicians should attend to a host of validated factors that are predictive of disease. However, research suggests that physicians may rely on demographic factors-such as race and gender. Physicians' judgments could also be influenced by non-health-related, personal information about their patients (e.g., hobbies, nicknames), which may moderate the impact of demographics on those judgments.

The investigators examine these dynamics in the context of heart disease. The History, Electrocardiogram, Age, Risk factors and Troponin (HEART) Score is a validated model that specifies a correspondence between certain risk factors and the likelihood of Major Adverse Cardiac Event (MACE). Importantly, there are substantially different diagnostic tests (e.g., noninvasive stress test versus coronary angiogram) that should be used depending on a patient's MACE likelihood.

Specifically, the investigators have three research questions:

* Research Question 1 (RQ1): How accurate are physicians relative to the benchmarks from the HEART score model?

* Research Question 2 (RQ2): How do clinically-relevant risk factors (e.g., smoking history), race, gender, and personal information disclosure influence risk judgments?

* Research Question 3 (RQ3): Does personal information disclosure moderate the effects of race and gender on risk judgments?

Note that when the investigators discuss accuracy and error, they are referring to the comparison of physician judgments to the HEART score model benchmarks.

Detailed Description

The investigators designed a survey to assess physicians' perception of MACE likelihood. Each physician rates a panel of patient profiles. The profiles randomly vary in risk factors, race, gender, and personal information disclosure (e.g., non-health related information about their hobbies). Using the HEART Score model as a benchmark, the investigators will assess how accurately physicians perceive MACE Likelihood based on the risk factors in a given profile. The investigators will further estimate how race, gender, and personal information disclosure causally affect physician judgments.

To do this, the investigators designed a mixed-design experiment. Each participant will respond to eight patient profiles that vary along three fully-crossed within-subject factors: (i) race: black vs. white, (ii) gender: man vs. woman, and (iii) risk factors: low vs. medium risk (based on risk levels from the HEART score model). Each participant will also be randomly assigned (between-subjects) to (iv) either see non-health-related personal information (e.g., hobbies) for all eight of their patients, or not see this information for any of their patients. The investigators refer to each factor as a profile attribute.

For each profile, participants indicate the perceived risk of a major adverse cardiac event in the six weeks following the visit. Our primary outcome is a measure of absolute error in perceived risk of MACE (described under the Primary Outcome section). They also indicate the diagnostic test they believe is most appropriate (Secondary Outcome #4).

Analysis plan

For all analyses, the investigators will format the data such that there are eight observations per participant, each corresponding to a patient profile the participant responded to.

* To test RQ1, the investigators will estimate an Ordinary Least Squares (OLS) regression predicting the primary outcome. The investigators will cluster standard errors by physician. The constant reflects the mean of our primary outcome, reflecting the extent to which physicians are inaccurate.

* To test RQ2, the investigators will estimate an OLS regression predicting the primary outcome. The independent variables include four indicators to model the profile attributes: an indicator for risk factors, an indicator for gender, an indicator for race, and an indicator for personal information disclosure. The model will also include fixed effects for physician specialty (emergency medicine, cardiologists, and hospitalists). The investigators will cluster standard errors by physician.

* To test RQ3, the investigators will reestimate the primary model testing RQ2 twice: In one model, the investigators will add an interaction term between personal information disclosure and race; and in the second model, the investigators will add an interaction term between personal information disclosure and gender.

As secondary analyses,

* The investigators will estimate the models above except using Secondary Outcomes Measures #1-3

* The investigators will measure participants' choice of appropriate diagnostic test for each patient as a secondary outcome (see Secondary Outcome #4). The investigators will estimate a multinomial logistic regression predicting choice of appropriate diagnostic test as the categorical outcome (with "routine follow-up" as the reference category). The independent variables include the four profile attribute indicators and physician specialty fixed effects. The investigators will cluster standard errors by physician.

* The investigators will reestimate the primary models testing RQ2, except including pairwise interactions between the physician specialty fixed effects and each of the four attributes.

* The investigators will reestimate the primary model testing RQ2, except adding all pairwise interactions between the four attributes as independent variables.

* The investigators will measure overconfidence (see Secondary Outcome Measure #5). With data at the physician-level, the investigators will estimate an OLS regression predicting overconfidence. The investigators will reestimate the model, except adding the two indicators for physician specialty and the indicator for personal information disclosure as independent variables.

The investigators will also measure and explore (i) qualitative open-ended responses about how they made their risk estimations, (ii) whether participants use the HEART score model at their jobs (or another model), (iii) if they use a model, why they use it, (iv) if they have heard of the HEART score model, (v) if they looked up anything while taking the study, and (vi) if yes, what they looked up.

The investigators plan to recruit 300 physicians using the Medscape panel.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Emergency medicine physicians
  • Cardiologists
  • Hospitalists (i.e., internists whose practice is primarily in the hospital)
  • If there are duplicate participant IDs in the data, only the first response will be included in the analysis
Exclusion Criteria
  • Participants who indicate they are retired
  • Participants who write gibberish in the open-ended items
  • Incomplete responses

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Absolute Error in Perceived Risk of MACEAt the time of survey completion, within approximately 2 weeks

For each patient profile, all participants will be asked about their perceived risk of MACE: What is the likelihood that this patient experiences a major adverse cardiac event in the six weeks following the visit? \[0-100\].

The paradigm uses two levels of risk factors, each associated with a specific risk of MACE range as defined by the HEART score model: low risk factors = 0.9-1.7% (midpoint = 1.3%); and medium risk factors = 12-16.6% (midpoint = 14.3%). To calculate each participant's directional error, the investigators will take the difference between participants' perceived risk of MACE and the midpoint of the risk of MACE range from the HEART score model at each patient's corresponding risk level.

The absolute error is calculated by taking the absolute value of the directional error.

Secondary Outcome Measures
NameTimeMethod
Perceived Risk of MACEAt the time of survey completion, within approximately 2 weeks

This reflects the raw, untransformed value of participants' response to the question: What is the likelihood that this patient experiences a major adverse cardiac event in the six weeks following the visit? \[0-100\].

Directional ErrorAt the time of survey completion, within approximately 2 weeks

This reflects the directional error variable, explained under the primary outcome description.

Categorical ErrorAt the time of survey completion, within approximately 2 weeks

This is a binary variable for whether participants' perceived risk of MACE falls outside of the HEART score model's risk of MACE range at each patient's corresponding risk level \[1 = outside of the range; 0 = within than range\].

Diagnostic Test DecisionAt the time of survey completion, within approximately 2 weeks

"What would you recommend for this patient?" \[(a) Coronary computed tomography angiography (cCTA), (b) noninvasive stress test, (c) left heart catheterization (coronary angiogram with potential percutaneous coronary intervention), or (d) routine follow-up.\]

OverconfidenceAt the time of survey completion, within approximately 2 weeks

"I believe my responses were more accurate than \_\_\_\_% of participants in this study." \[0 to 100; there is more information in the survey about the meaning of "accurate" and the response options\]. To measure true percentile placement, the investigators will calculate each participant's mean absolute error of perceived risk of MACE across the eight profiles and then calculate their percentile rank. The investigators will then calculate overconfidence by taking the difference between their perceived and true percentile placement. Note that this is specifically a measure of over-placement (rather than over-precision or over-estimation).

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.